Skip to main content

Policy Committee Meeting

Tuesday January 21, 2025

Agenda

  • Call to order
  • Executive Director Report
  • Old business
  • Chair report, new business
  • Call to adjourn

Materials provided

  • Agenda
  • Meeting Minutes
  • Related documents

Minutes

Meeting started at 4:11 pm due to technical difficulties

Approval of previous meeting minutes

Action: Dawn Stenstrom made a motion to approve December meeting minutes. Motion approved by Dan Endreson and seconded by Rae Blaylark. All in favor.

Debrief of Drug Formulary Committee Presentation

The policy committee discussed issues and concerns raised during the full council meeting, most notably concerns regarding the drug formulary committee’s public comment process. The committee discussed how to incorporate learnings into the proposed legislation that the Council will introduce related to drug formulary modifications.

Review of current proposed RDAC legislation

Erica Barnes provided updates on the status of council priorities. Ongoing discussion around prioritizing funding to ensure Council sustainability.

Presentation on finding related to DFC’s public comment process versus Medicaid and FDA public comment processes

Council policy manager Natalie Schmidt presented information on the public comment process used by CMS and the FDA as a possible guide for council drug formulary public comment modifications. Committee discussed how to best scope the legislation while addressing community concerns related to drug formulary process.


Motion to adjourn by Dawn Stenstrom, seconded by Rae Blaylark.

Submitted by Erica Barnes